# Energy Homeostasis Under Treatment With Atypical Antipsychotics

> **NCT00148564** · PHASE4 · COMPLETED · sponsor: **Charite University, Berlin, Germany** · enrollment: 40 (actual)

## Conditions studied

- Schizophrenia

## Interventions

- **DRUG:** olanzapine
- **DRUG:** Ziprasidone

## Key facts

- **NCT ID:** NCT00148564
- **Lead sponsor:** Charite University, Berlin, Germany
- **Sponsor class:** OTHER
- **Phase:** PHASE4
- **Study type:** INTERVENTIONAL
- **Status:** COMPLETED
- **Start date:** 2004-03
- **Primary completion:** 2007-03
- **Final completion:** 2007-06
- **Target enrollment:** 40 (ACTUAL)
- **Last updated:** 2008-09-29


## Primary source

ClinicalTrials.gov registry: https://clinicaltrials.gov/study/NCT00148564

## Citation

> US National Library of Medicine, ClinicalTrials.gov registration NCT00148564, "Energy Homeostasis Under Treatment With Atypical Antipsychotics". Retrieved via AI Analytics 2026-05-31 from https://api.ai-analytics.org/clinical/NCT00148564. Licensed CC0.

---

*[Clinical trials dataset](/datasets/clinical-trials) · CC0 1.0*